# US 2014/0271910 A1 · Methods for treating urushiol-induced contact dermatitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0271910 A1
- Document ID: US20140271910A1
- Status: Published application
- Kind: A1
- Application number: 14/201,980
- Filed: 2014-03-10
- Published: 2014-09-18
- Earliest claimed: 2013-03-15
- Assignees: Stemnion, Inc.
- Applicants: Stemnion, Inc.
- Inventors: Larry R. Brown; Linda O. Palladino
- Web page: https://patentgrep.com/patent/US20140271910A1

## CPC

- A61K 35/50: Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention is directed to methods for treating urushiol-induced contact dermatitis. Specifically, the invention is directed to treating and reducing inflammation associated with poison ivy, poison sumac and poison oak by administering to a subject suffering from such conditions novel cellular factor-containing solution compositions (referred to herein as “CFS” compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as “SR-CFS” compositions).

## Claims

### Claim 1

A method for treating urushiol-induced contact dermatitis in a patient in need thereof comprising administering to the patient a therapeutically effective amount of a CFS composition.

### Claim 2 (depends on 1)

The method of claim 1 wherein the CFS composition is ACCS.

### Claim 3 (depends on 2)

The method of claim 2 wherein the CFS composition, including ACCS, is formulated for topical administration.

### Claim 4 (depends on 1)

The method of claim 1 wherein the urushiol-induced contact dermatitis is selected from the group consisting of poison ivy, poison sumac and poison oak.

### Claim 5

A method for reducing inflammation associated with urushiol-induced contact dermatitis in a patient in need thereof comprising administering to the patient a therapeutically effective amount of a CFS composition such that inflammation associated with urushiol-induced contact dermatitis is reduced.

### Claim 6 (depends on 5)

The method of claim 5 wherein the CFS composition is ACCS.

### Claim 7 (depends on 6)

The method of claim 6 wherein the CFS composition, including ACCS, is formulated for topical administration.

### Claim 8 (depends on 5)

The method of claim 5 wherein the urushiol-induced contact dermatitis is selected from the group consisting of poison ivy, poison sumac and poison oak.

### Claim 9

A kit comprising a CFS composition and instructions for its use to treat urushiol-induced contact dermatitis.

### Claim 10 (depends on 9)

The kit of claim 9 wherein the CFS composition is ACCS.

### Claim 11 (depends on 10)

The kit of claim 10 wherein the CFS composition, including ACCS, is formulated for topical administration.
